Shopping Cart
Remove All
Your shopping cart is currently empty
Romosozumab (Synonyms: CDP-7851, CDP7851, AMG-785, AMG785)
Catalog No. T77380 Copy Product Info
🥰Excellent
Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis.
Romosozumab
Copy Product Info🥰Excellent
Catalog No. T77380
Synonyms CDP-7851, CDP7851, AMG-785, AMG785
Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis.
Romosozumab
Cas No. 909395-70-6
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $232 | - | In Stock | |
| 5 mg | $581 | - | In Stock | |
| 10 mg | $930 | - | In Stock | |
| 25 mg | $1,581 | - | In Stock | |
| 50 mg | $2,370 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:98.9% (SDS-PAGE); 98.2% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Romosozumab (AMG-785) is a humanized monoclonal antibody that binds and inhibits sclerostin, increasing bone formation and decreasing bone resorption.Romosozumab is used in the study of postmenopausal osteoporosis. |
| In vivo | Romosozumab (30 mg/kg twice weekly for 10 weeks) induces the transformation of bone trabecular rod-like structures to plate-like structures in cynomolgus monkeys. [1] In mature cynomolgus monkeys undergoing ovariectomy for 4 months, Romosozumab (3 mg/kg and 30 mg/kg once weekly for 6 or 12 months) was able to enhance bone mass, optimize bone structure, and improve bone strength while maintaining bone quality. [2] |
| Synonyms | CDP-7851, CDP7851, AMG-785, AMG785 |
| Reactivity | Human |
| Verified Activity | Immobilized Human SOST Protein (His) (TMPY-00925) at 1 μg/mL (100 μL/well) can bind Romosozumab. The EC50 is 16.42 ng/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | SOST/Sclerostin |
| Molecular Weight | 145.87 kDa |
| Cas No. | 909395-70-6 |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Romosozumab | purchase Romosozumab | Romosozumab cost | order Romosozumab | Romosozumab in vivo | Romosozumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.